- Home
- MPU vs GRCE Comparison
MPU vs GRCE Comparison
Compare MPU & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- GRCE
- Stock Information
- Founded
- MPU 1989
- GRCE 2002
- Country
- MPU Singapore
- GRCE United States
- Employees
- MPU N/A
- GRCE N/A
- Industry
- MPU Transportation Services
- GRCE
- Sector
- MPU Consumer Discretionary
- GRCE
- Exchange
- MPU Nasdaq
- GRCE NYSE
- Market Cap
- MPU 35.5M
- GRCE 40.0M
- IPO Year
- MPU 1998
- GRCE N/A
- Fundamental
- Price
- MPU $0.87
- GRCE $2.97
- Analyst Decision
- MPU
- GRCE Strong Buy
- Analyst Count
- MPU 0
- GRCE 1
- Target Price
- MPU N/A
- GRCE $12.00
- AVG Volume (30 Days)
- MPU 267.8K
- GRCE 18.1K
- Earning Date
- MPU 06-17-2025
- GRCE 06-17-2025
- Dividend Yield
- MPU N/A
- GRCE N/A
- EPS Growth
- MPU N/A
- GRCE N/A
- EPS
- MPU N/A
- GRCE N/A
- Revenue
- MPU $36,184,000.00
- GRCE N/A
- Revenue This Year
- MPU N/A
- GRCE N/A
- Revenue Next Year
- MPU N/A
- GRCE N/A
- P/E Ratio
- MPU N/A
- GRCE N/A
- Revenue Growth
- MPU N/A
- GRCE N/A
- 52 Week Low
- MPU $0.49
- GRCE $1.75
- 52 Week High
- MPU $1.98
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- MPU 47.20
- GRCE N/A
- Support Level
- MPU $0.80
- GRCE N/A
- Resistance Level
- MPU $0.92
- GRCE N/A
- Average True Range (ATR)
- MPU 0.09
- GRCE 0.00
- MACD
- MPU -0.01
- GRCE 0.00
- Stochastic Oscillator
- MPU 32.22
- GRCE 0.00
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.